查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1438230

2030 年成药市场预测：按产品、剂型、给药途径、分销管道、最终用户和地区进行的全球分析

Over the Counter Market Forecasts to 2030 - Global Analysis By Product, Dosage Form, Route of Administration, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球成药市场规模为 1,733.4 亿美元，预计到 2030 年将达到 2,783.4 亿美元，预测期内复合年增长率为 7.0%。

成药(OTC) 是指无需医疗保健专业人员处方笺即可购买的药物。这些药物为消费者提供了便捷的解决方案，在解决感冒、身体疼痛、过敏和流感、胃灼热、痤疮等轻微健康问题方面发挥重要作用。成药的例子包括对乙酰胺酚、阿斯匹灵、制酸剂、减充血剂、抗组织胺药物和泻药。这些药物由许多国家的监管机构选择，以确保它们含有无需医疗监督即可安全有效服用的化学物质。

美国国立卫生研究院报告称，93%的美国成年人更成药。用成药治疗轻微疾病。

自我治疗需求不断成长

随着越来越多的人寻求无需处方笺即可轻鬆获得的治疗方法，自我治疗变得越来越流行。这些药物现在可以在药局、超级市场、便利商店以及最近的线上平台上买到。这种可用性使消费者可以轻鬆购买治疗小病和日常健康问题的药物。成药的另一个优点是它们比处方笺药便宜。对负担能力和可近性的关注鼓励消费者将事情掌握在自己手中，从而促进了成药市场的整体成长。

安全问题

无需处方笺即可获得的成药存在因误用、滥用和消费者自行服用而产生副作用的风险。对于无法获得专业医疗指引的消费者来说，剂量不正确、药物交互作用以及在需要专业介入的情况下依赖非处方药的可能性会增加。这导致监管机构加强审查，以确保消费者安全。如果出现副作用或安全问题，可能会发生产品召回或监管，这可能会影响市场动态。

世界老化

随着世界人口老化，与老龄化相关的健康问题和慢性病的盛行率也增加。成药满足了老年人日益增长的自我治疗需求，为常见疾病提供了方便且经济高效的解决方案。此外，老龄化往往伴随着各种健康问题，包括关节疼痛、关节炎、心血管问题和消化器官系统问题。成药可以为这些常见疾病提供便捷的解决方案，无需处方笺。非处方药产品，包括维生素、补充品和健康专用药物，符合维持整体健康和预防老龄化相关问题的趋势。

与学名药的竞争

学名药的推出通常比品牌成药便宜，这加剧了市场竞争并使知名公司面临压力。符合监管标准的学名药选择可能会降低报酬率并减少品牌成药的市场占有率。此外，随着学名药的出现，品牌非成药可能会失去排他性，这可能导致市场排他性下降并影响品牌药的销售和收益。

COVID-19 的影响

疫情期间，由于健康意识增强、预防措施增加以及自我护理产品需求增加，非处方药销售量激增。消费者寻求常见病症的治疗方法，推动了免疫增强剂、止咳药和感冒药以及卫生用品的销售。然而，供应链中断、消费者支出模式变化以及经济不确定性也带来了挑战。这次疫情凸显了非处方药产业适应性和创新的重要性，并塑造了消费行为和市场动态的新趋势。

预计在预测期内镇痛领域将是最大的。

预计镇痛领域将占最大份额。镇痛药是用于控制和治疗疼痛的药物。通常用于缓解轻度至中度疼痛的止痛药包括常见的成药，如对乙酰胺酚、Ibuprofen和阿斯匹灵。这些药物可治疗多种疼痛，包括头痛、肌肉疼痛、月经疼痛和轻微关节疼痛。镇痛药细分市场的特点是易于取得、易于使用和消费者广泛接受，对成药市场的整体成长做出了重大贡献。

预计锭剂产业在预测期内复合年增长率最高

预计锭剂市场在预测期内将出现良好成长。锭剂是固态压缩药物型态，含有活性成分和各种赋形剂。由于每锭剂含有标准化量的活性成分，因此锭剂可以精确控制剂量。这确保了剂量的一致性并帮助消费者遵守建议的使用指南。此外，锭剂具有多种治疗作用，可以解决疼痛、过敏、消化器官系统问题和营养缺乏等问题。锭剂因其方便、剂量准确且可提供多种药物而在成药市场上广泛使用和流行。

比最大的地区

由于医疗保健意识的提高、可支配收入的增加和人口的增长，亚太地区在预测期内占据了最大的市场占有率。忙碌的生活方式、容易取得的资讯以及对非处方笺药的偏好等因素正在推动自我治疗的趋势。此外，由于文化差异、医疗保健实践和历史因素，各国的偏好和购买行为也有所不同。了解这些细微差别对于希望在该地区建立强大影响力的公司至关重要。

复合年增长率最高的地区：

预计北美在预测期内将实现盈利成长。北美消费者通常更喜欢自我护理和非处方解决方案来解决常见的健康问题。这一趋势是由便利性、可用性以及无需处方笺即可治疗小病的愿望等因素所推动的。北美的法规环境明确，美国食品药物管理局(FDA) 和加拿大卫生署监督监督成药的核准和监管。此外，北美OTC市场竞争激烈，国内外药企竞相争取市场占有率。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球成药市场：副产品

  • 止痛药
  • 消化和肠道疗法
  • 感冒和咳嗽的补救措施
  • 维生素和矿物质
  • 皮肤科产品
  • 其他产品

第六章全球成药市场：按剂型

  • 锭剂
  • 软膏
  • 液体
  • 喷
  • 其他剂型

第七章 全球成药市场：依给药途径分类

  • 口服
  • 胃肠外的
  • 外用
  • 其他给药途径

第八章全球成药市场：依分销管道分类

  • 药局和零售药局
  • 网路药房
  • 医院药房

第九章 全球成药市场：依最终用户分类

  • 专科诊所
  • 医院
  • 居家照护
  • 其他最终用户

第十章 全球成药市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Bayer AG
  • Pfizer
  • Takeda Pharmaceutical Company Ltd.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Sanofi SA
  • GlaxoSmithKline PLC
  • Reckitt Benckiser Group PLC
  • Boehringer Ingelheim International GmbH
  • Mylan
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Cipla, Inc
  • Glenmark Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories
  • Alkem Laboratories Limited
  • Viatris, Inc
  • The Blackstone Group, Inc.
  • Aytu Biopharma, Inc.
  • Merck & Co. Inc.
Product Code: SMRC25199

According to Stratistics MRC, the Global Over the Counter Drug Market is accounted for $173.34 billion in 2023 and is expected to reach $278.34 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Over-the-Counter (OTC) drugs refer to medications that are available for purchase without a prescription from a healthcare professional. These drugs play a crucial role in providing accessible and convenient solutions for consumers to address minor health issues like common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems. Acetaminophen, aspirin, antacids, decongestants, antihistamines, and laxatives are the examples of OTC drugs. These drugs are chosen by regulatory agencies in many countries to guarantee that they contain chemicals that are safe and effective when taken without the supervision of a physician.

According to a National Institute of Health report, 93% of adults in the U.S. prefer to treat minor illnesses with over the counter drugs before seeking professional help, and 85% of parents prefer to treat minor illnesses in their children with over the counter drugs before seeking professional help.

Market Dynamics:

Driver:

Growing demand for self-medications

Self-medication becomes increasingly popular as people explore readily accessible remedies without a prescription. These medications are readily available in pharmacies, supermarkets, convenience stores, and increasingly through online platforms. This accessibility allows consumers to easily purchase medications for minor ailments and everyday health concerns. Moreover, affordability is a key advantage of OTC drugs compared to prescription medications. With a focus on affordability and ease of access, the market benefits from consumers' preference for managing minor health issues on their own, contributing to the overall growth of the OTC Drug Market.

Restraint:

Safety concerns

OTC drugs, available without a prescription, pose risks of misuse, abuse, and adverse effects due to self-administration by consumers. As individuals may lack professional medical guidance, there's an increased potential for incorrect dosage, drug interactions, or reliance on OTC options for conditions requiring professional intervention. This raises regulatory scrutiny to ensure consumer safety. Instances of adverse reactions or safety issues may result in product recalls or restrictions, impacting market dynamics.

Opportunity:

Global aging population

As the world's population ages, there is a concurrent increase in the prevalence of age-related health issues and chronic conditions. OTC drugs cater to the rising demand for self-medication among the elderly, offering accessible and cost-effective solutions for common ailments. Moreover, aging is often associated with various health concerns, such as joint pain, arthritis, cardiovascular issues, and digestive problems. OTC drugs provide a convenient solution for managing these common ailments without the need for a prescription. OTC products, including vitamins, supplements, and wellness-focused medications, align with the trend of maintaining overall health and preventing age-related issues.

Threat:

Competition from generic drugs

The introduction of generic substitutes, which are frequently less expensive than branded over-the-counter medications, increases market rivalry and put well-known companies under pressure. Generic options, while meeting regulatory standards, can erode profit margins and diminish the market share of branded OTC drugs. Also, the branded OTC drugs may lose their exclusivity as generic options become available, leading to a reduction in market exclusivity and potentially impacting the sales and revenue of the original products.

Covid-19 Impact

Increased health awareness, preventive measures, and heightened demand for self-care products during the pandemic led to a surge in OTC sales. Consumers sought remedies for common symptoms, boosting sales of immune boosters, cough and cold medications, and hygiene-related products. However, disruptions in the supply chain, changes in consumer spending patterns, and economic uncertainties also presented challenges. The pandemic underscored the importance of adaptability and innovation in the OTC industry, shaping new trends in consumer behaviour and market dynamics.

The analgesics segment is expected to be the largest during the forecast period

The analgesics segment is estimated to hold the largest share. Analgesics are medications used in the management and treatment of pain. Widely used to alleviate mild to moderate pain, analgesics include common OTC drugs such as acetaminophen, ibuprofen, and aspirin. These medications addresses a broad spectrum of pain conditions, including headaches, muscle pain, menstrual cramps, and minor arthritis pain. The analgesics segment is characterized by its accessibility ease of use, and broad consumer acceptance, contributing significantly to the overall OTC drug market's growth

The tablets segment is expected to have the highest CAGR during the forecast period

The tablets segment is anticipated to have lucrative growth during the forecast period. Tablets are solid, compressed forms of medication, containing active ingredients along with various excipients. Tablets offer precise dosage control, with each tablet containing a standardized amount of the active ingredient. This ensures consistency in dosing and helps consumers follow recommended usage guidelines. Moreover, they cater to various therapeutic areas, addressing conditions like pain, allergies, digestive issues, and nutritional deficiencies. The convenience, precision in dosing, and broad range of medications available in tablet form contribute to their widespread use and popularity in the OTC drug market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing healthcare awareness, rising disposable incomes, and a growing population. There's a notable trend towards self-medication, driven by factors such as busy lifestyles, easy access to information, and a preference for non-prescription solutions. Moreover, preferences and buying behaviours vary across countries due to cultural differences, healthcare practices, and historical factors. Understanding these nuances is essential for companies aiming to establish a strong presence in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Consumers in North America often prefer self-care and over-the-counter solutions for common health issues. This trend is driven by factors like convenience, accessibility, and the desire to manage minor ailments without the need for a prescription. The regulatory environment in North America is well-defined, with the U.S. Food and Drug Administration (FDA) and Health Canada overseeing the approval and regulation of OTC drugs. Furthermore, the North American OTC market is highly competitive, with both domestic and multinational pharmaceutical companies vying for market share.

Key players in the market

Some of the key players in the Over the Counter Drug Market include Bayer AG, Pfizer, Takeda Pharmaceutical Company Ltd., Johnson & Johnson Services Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Boehringer Ingelheim International GmbH, Mylan, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Cipla Inc., Glenmark Pharmaceuticals Ltd, Dr. Reddy's Laboratories, Alkem Laboratories Limited, Viatris, Inc, The Blackstone Group, Inc., Aytu Biopharma, Inc. and Merck & Co. Inc.

Key Developments:

In June 2022, Glenmark Pharmaceuticals Ltd. acquired a portfolio of approved OTC abbreviated new drug applications (ANDAs) in the U.S. from Wockhardt. The acquired ANDAs helped the company expand its OTC portfolio in the U.S.

In June 2021, Bayer announced the approval of Astepro Allergyfrom the U.S. Food and Drug (FDA) as an over the counter (OTC) product for the temporary relief of nasal congestion runny nose and Itchy nose and other respiratory allergies.

Products Covered:

  • Analgesics
  • Digestives & Intestinal Remedies
  • Cold & Cough Remedies
  • Vitamins & Minerals
  • Dermatological Products
  • Other Products

Dosage Forms Covered:

  • Tablets
  • Ointments
  • Liquids
  • Sprays
  • Other Dosage Forms

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Topical
  • Other Routes of Administration

Distribution Channels Covered:

  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

End Users Covered:

  • Speciality Clinic
  • Hospital
  • Homecare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Over the Counter Drug Market, By Product

  • 5.1 Introduction
  • 5.2 Analgesics
  • 5.3 Digestives & Intestinal Remedies
  • 5.4 Cold & Cough Remedies
  • 5.5 Vitamins & Minerals
  • 5.6 Dermatological Products
  • 5.7 Other Products

6 Global Over the Counter Drug Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Tablets
  • 6.3 Ointments
  • 6.4 Liquids
  • 6.5 Sprays
  • 6.6 Other Dosage Forms

7 Global Over the Counter Drug Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Other Routes of Administration

8 Global Over the Counter Drug Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Drug Stores & Retail Pharmacies
  • 8.3 Online Pharmacies
  • 8.4 Hospital Pharmacies

9 Global Over the Counter Drug Market, By End User

  • 9.1 Introduction
  • 9.2 Speciality Clinic
  • 9.3 Hospital
  • 9.4 Homecare
  • 9.5 Other End Users

10 Global Over the Counter Drug Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Bayer AG
  • 12.2 Pfizer
  • 12.3 Takeda Pharmaceutical Company Ltd.
  • 12.4 Johnson & Johnson Services Inc.
  • 12.5 Novartis AG
  • 12.6 Sanofi S.A.
  • 12.7 GlaxoSmithKline PLC
  • 12.8 Reckitt Benckiser Group PLC
  • 12.9 Boehringer Ingelheim International GmbH
  • 12.10 Mylan
  • 12.11 Sun Pharmaceutical Industries Ltd
  • 12.12 Teva Pharmaceutical Industries Ltd
  • 12.13 Cipla, Inc
  • 12.14 Glenmark Pharmaceuticals Ltd
  • 12.15 Dr. Reddy's Laboratories
  • 12.16 Alkem Laboratories Limited
  • 12.17 Viatris, Inc
  • 12.18 The Blackstone Group, Inc.
  • 12.19 Aytu Biopharma, Inc.
  • 12.20 Merck & Co. Inc.

List of Tables

  • Table 1 Global Over the Counter Drug Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Over the Counter Drug Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Over the Counter Drug Market Outlook, By Analgesics (2021-2030) ($MN)
  • Table 4 Global Over the Counter Drug Market Outlook, By Digestives & Intestinal Remedies (2021-2030) ($MN)
  • Table 5 Global Over the Counter Drug Market Outlook, By Cold & Cough Remedies (2021-2030) ($MN)
  • Table 6 Global Over the Counter Drug Market Outlook, By Vitamins & Minerals (2021-2030) ($MN)
  • Table 7 Global Over the Counter Drug Market Outlook, By Dermatological Products (2021-2030) ($MN)
  • Table 8 Global Over the Counter Drug Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Over the Counter Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 10 Global Over the Counter Drug Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 11 Global Over the Counter Drug Market Outlook, By Ointments (2021-2030) ($MN)
  • Table 12 Global Over the Counter Drug Market Outlook, By Liquids (2021-2030) ($MN)
  • Table 13 Global Over the Counter Drug Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 14 Global Over the Counter Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 15 Global Over the Counter Drug Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 16 Global Over the Counter Drug Market Outlook, By Oral (2021-2030) ($MN)
  • Table 17 Global Over the Counter Drug Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 18 Global Over the Counter Drug Market Outlook, By Topical (2021-2030) ($MN)
  • Table 19 Global Over the Counter Drug Market Outlook, By Other Routes of Administration (2021-2030) ($MN)
  • Table 20 Global Over the Counter Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 21 Global Over the Counter Drug Market Outlook, By Drug Stores & Retail Pharmacies (2021-2030) ($MN)
  • Table 22 Global Over the Counter Drug Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 23 Global Over the Counter Drug Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 24 Global Over the Counter Drug Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Over the Counter Drug Market Outlook, By Speciality Clinic (2021-2030) ($MN)
  • Table 26 Global Over the Counter Drug Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 27 Global Over the Counter Drug Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 28 Global Over the Counter Drug Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.